Clinical implications and prognostic value of EMMPRIN/CD147 and MMP2 expression in pediatric gliomas

European Journal of Pediatrics

Volumn 168, Issue 6, 2009, Pages 705-710

  Gu, Jian ^a   Zhang, Che ^a   Chen, Rongguang ^a   Pan, Jun ^a   Wang, Yong ^a   Ming, Meng ^a   Gui, Weixing ^a   Wang, Dabin ^a  

^a HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

Clinical pathology; EMMPRIN; MMP2; Pediatric glioma; Prognosis

Indexed keywords

CD147 ANTIGEN; GELATINASE A;

ARTICLE; BRAIN TISSUE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SCHOOL CHILD; SURVIVAL;

ANTIGENS, CD147; ASTROCYTOMA; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MATRIX METALLOPROTEINASE 2; PROGNOSIS;

EID: 67349256425     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-008-0828-5     Document Type: Article

References (24)

1. DJ Brat BM Shehata AA Castellano-Sanchez 2007 Congenital glioblastoma: a clinicopathologic and genetic analysis Brain Pathol 17 276 281 (Pubitemid 47000636)
2. EA Marieb A Zoltan-Jones 2004 Emmprin promotes anchorage-independent growth in human mammary carcinoma cells by stimulating hyaluronan production Cancer Res 64 1229 1232 (Pubitemid 38235586)
3. EE Gabison S Mourah E Steinfels 2005 Differential expression of extracellular matrix metalloproteinase inducer (CD147) in normal and ulcerated corneas: role in epithelio- stromal interactions and matrix metalloproteinase induction Am J Pathol 166 209 219 (Pubitemid 40051673)
4. KJ Heppner LM Matrisian RA Jensen 1996 Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response Am J Pathol 149 273 282 (Pubitemid 26230998)
5. J Sun ME Hemle 2001 Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions Cancer Res 61 2276 2281 (Pubitemid 32692059)
6. P Kleihues PC Burger BW Scheithauer 1993 The new WHO classification of brain tumours Brain Pathol 3 255 268 (Pubitemid 23276692)
7. AE Kossakowska SA Huchcroft SJ Urbanski 1996 Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans Br J Cancer 73 1401 1408
8. CA London HS Sekhon V Arora 2003 A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity Cancer Gene Ther 10 823 832 (Pubitemid 37420041)
9. MC Madigan EA Kingsley PJ Cozzi 2008 The role of extracellular matrix metalloproteinase inducer protein in prostate cancer progression Cancer Immunol Immunother 57 1367 1379
10. M Lanyi CR Antonescu 2002 The precrystalline cytoplasmic granules of alveolar soft part sarcoma contain monocarboxylate transporter 1 and CD147 Am J Pathol 160 1215 1221 (Pubitemid 34411625)
11. Z Mi T Oliver H Guo 2007 Thrombin-cleaved COOH (-) terminal osteopontin peptide binds with cyclophilin C to CD147 in murine breast cancer cells Cancer Res 67 4088 4097 (Pubitemid 46815053)
12. K Nabeshima H Iwasaki K Koga 2006 Emmprin (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression Pathol Int 56 359 367 (Pubitemid 43886799)
13. M Nakada H Nakamura E Ikeda 1999 Expression and tissue localization of membrane-types 1, 2 and 3 matrix metalloproteinases in human astrocytic tumors Am J Pathol 154 417 428 (Pubitemid 29094092)
14. SM Pulukuri S Patibandla J Patel 2007 Epigenetic inactivation of the tissue inhibitor of metalloproteinase-2 (TIMP-2) gene in human prostate tumors Oncogene 26 5229 5237 (Pubitemid 47237624)
15. NG Rainov A Söling 2006 Clinical studies with targeted toxins in malignant glioma Rev Recent Clin Trials 1 119 131
16. SM Ranuncolo E Armanasco C Cresta 2003 Plasma MMP-9 (92 kDa-MMP) activity is useful in the follow-up and in the assessment of prognosis in breast cancer patients Int J Cancer 106 745 751 (Pubitemid 36993399)
17. S Riethdorf N Reimers V Assmann 2006 High incidence of EMMPRIN expression in human tumors Int J Cancer 119 1800 1810 (Pubitemid 44356836)
18. W Sienel J Hellers A Morresi-Hauf 2003 Prognostic impact of matrix metalloproteinase-9 in operable non-small cell lung cancer Int J Cancer 103 647 651 (Pubitemid 36091469)
19. S Zucker M Hymowitz EE Rollo 2001 Tumorigenic potential of extracellular matrix metalloproteinase inducer Am J Pathol 158 1921 1928 (Pubitemid 32545174)
20. R Stupp WP Mason MJ van den Bent 2005 Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 987 996 (Pubitemid 40349501)
21. P Vihinen VM Kahari 2002 Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets Int J Cancer 99 157 166 (Pubitemid 34309470)
22. J Wykosky DM Gibo C Stanton 2005 EphA2 as a novel molecular marker and target in glioblastoma multiform Mol Cancer Res 3 541 551 (Pubitemid 41567273)
23. Y Tang MT Nakada 2005 Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating ascular endothelial cell growth factor and matrix metalloproteinases Cancer Res 65 3193 3199 (Pubitemid 40524601)
24. Y Ishibashi T Matsumoto M Niwa 2004 CD147 and matrix metalloproteinase-2 protein expression as significant prognostic factors in esophageal squamous cell carcinoma Cancer 101 1994 2000 (Pubitemid 39425374)